EP3609573C0 - Vorrichtung zur transkutanen bestrahlung zur behandlung von neurodegenerativen krankheiten - Google Patents

Vorrichtung zur transkutanen bestrahlung zur behandlung von neurodegenerativen krankheiten

Info

Publication number
EP3609573C0
EP3609573C0 EP18717620.1A EP18717620A EP3609573C0 EP 3609573 C0 EP3609573 C0 EP 3609573C0 EP 18717620 A EP18717620 A EP 18717620A EP 3609573 C0 EP3609573 C0 EP 3609573C0
Authority
EP
European Patent Office
Prior art keywords
treatment
irradiation device
neurodegenerative diseases
transcutaneous irradiation
transcutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP18717620.1A
Other languages
English (en)
French (fr)
Other versions
EP3609573A1 (de
EP3609573B1 (de
Inventor
Guillaume Blivet
Guillaume Moreau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regenlife SAS
Original Assignee
Regenlife SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenlife SAS filed Critical Regenlife SAS
Publication of EP3609573A1 publication Critical patent/EP3609573A1/de
Application granted granted Critical
Publication of EP3609573B1 publication Critical patent/EP3609573B1/de
Publication of EP3609573C0 publication Critical patent/EP3609573C0/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/002—Magnetotherapy in combination with another treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0622—Optical stimulation for exciting neural tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0626—Monitoring, verifying, controlling systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645—Applicators worn by the patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645—Applicators worn by the patient
    • A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
    • A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Radiation-Therapy Devices (AREA)
  • Magnetic Treatment Devices (AREA)
  • Medicinal Preparation (AREA)
EP18717620.1A 2017-04-14 2018-04-13 Vorrichtung zur transkutanen bestrahlung zur behandlung von neurodegenerativen krankheiten Active EP3609573B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17305450 2017-04-14
PCT/EP2018/059596 WO2018189393A1 (fr) 2017-04-14 2018-04-13 Dispositif d'irradiation transcutanée et application au traitement des maladies neurodégénératives

Publications (3)

Publication Number Publication Date
EP3609573A1 EP3609573A1 (de) 2020-02-19
EP3609573B1 EP3609573B1 (de) 2025-03-19
EP3609573C0 true EP3609573C0 (de) 2025-03-19

Family

ID=58644984

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18717620.1A Active EP3609573B1 (de) 2017-04-14 2018-04-13 Vorrichtung zur transkutanen bestrahlung zur behandlung von neurodegenerativen krankheiten

Country Status (9)

Country Link
US (1) US11524170B2 (de)
EP (1) EP3609573B1 (de)
JP (1) JP7213864B2 (de)
CN (1) CN110831661B (de)
AU (1) AU2018252199B2 (de)
CA (1) CA3059648A1 (de)
ES (1) ES3030782T3 (de)
SA (1) SA519410296B1 (de)
WO (1) WO2018189393A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220105361A1 (en) * 2019-01-11 2022-04-07 SYMBYX Pty Ltd Use of photobiomodulation therapy to treat inflammatory and/or metabolic conditions
GB2587222A (en) * 2019-09-19 2021-03-24 Dglp Ltd Device for destroying extended beta-amyloid
KR102372895B1 (ko) * 2019-11-06 2022-03-11 계명대학교 산학협력단 해마 조직에서 뇌유래신경성장인자(Brain-derived neurotrophic factor, BDNF) 활성 유도를 위한 포토바이오모듈레이션(Photobiomodulation, PBMT 또는 PBM) 방법 및 시스템
KR200498115Y1 (ko) 2020-05-04 2024-07-03 비티엘 헬쓰케어 테크놀로지스 에이.에스. 환자의 미용 시술을 위한 디바이스
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
IT202100022319A1 (it) * 2021-08-26 2021-11-26 Samtech S R L Sistema di fotobiomodulazione cerebrale
IT202100022322A1 (it) * 2021-08-26 2021-11-26 Samtech S R L Sistema di fotobiomodulazione cerebrale non invasivo
WO2024209265A1 (en) * 2023-04-05 2024-10-10 Cerathrive Ltd. System and method for irradiating a brain and at least one body part of a user

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0226568A (ja) * 1988-07-18 1990-01-29 Nec Corp 電気治療器
JPH06231B2 (ja) * 1989-04-04 1994-01-05 遠州軽合金株式会社 軽合金製ホイールの塗装方法
RU2145247C1 (ru) * 1998-04-10 2000-02-10 Жаров Владимир Павлович Фотоматричное терапевтическое устройство для лечения протяженных патологий
US6974224B2 (en) 2003-07-30 2005-12-13 Tru-Light Corporation Modularized light processing of body components
US20070129776A1 (en) 2005-10-20 2007-06-07 Light Sciences Llc External wearable light therapy treatment systems
US10695579B2 (en) * 2006-01-30 2020-06-30 Pthera LLC Apparatus and method for indicating treatment site locations for phototherapy to the brain
CN101378806B (zh) * 2006-02-06 2014-05-07 皇家飞利浦电子股份有限公司 身体护罩、眼镜和/或至少局部的头部护罩，用于辐射人体的至少一部分的方法和身体护罩的使用
JP2011515152A (ja) * 2008-03-18 2011-05-19 フォトテラ・インコーポレーテッド 表面を連続波またはパルス光で照射するための方法および装置
WO2011146777A2 (en) * 2010-05-19 2011-11-24 Photothera, Inc. Device and method for providing a synergistic combination of phototherapy and a non-light energy modality to the brain
CN106413810B (zh) * 2015-03-20 2020-08-14 L·林 用于脑的非侵入式神经刺激治疗的系统和装置
CN106390299B (zh) * 2016-11-03 2018-08-10 厦门开元光学健康应用研究所 一种光疗装置的辐照器

Also Published As

Publication number Publication date
CN110831661B (zh) 2022-08-09
US11524170B2 (en) 2022-12-13
CN110831661A (zh) 2020-02-21
JP7213864B2 (ja) 2023-01-27
SA519410296B1 (ar) 2023-12-14
ES3030782T3 (en) 2025-07-02
US20210113846A1 (en) 2021-04-22
AU2018252199A1 (en) 2019-12-05
EP3609573A1 (de) 2020-02-19
EP3609573B1 (de) 2025-03-19
CA3059648A1 (fr) 2018-10-18
AU2018252199B2 (en) 2024-01-11
JP2020516426A (ja) 2020-06-11
WO2018189393A1 (fr) 2018-10-18

Similar Documents

Publication Publication Date Title
EP3720553C0 (de) Fotobiomodulatationsvorrichtung zur behandlung von netzhautkrankheiten
EP3609573C0 (de) Vorrichtung zur transkutanen bestrahlung zur behandlung von neurodegenerativen krankheiten
EP3893940A4 (de) Kombinationstherapie zur behandlung von muskeldystrophie
EP3618829A4 (de) Chinazolin-pyridin-derivate zur behandlung von krebsbedingten erkrankungen
EP3538548A4 (de) Il-2-varianten zur behandlung von autoimmunerkrankungen
EP3579797C0 (de) Vorrichtung zur fotothermischen ophthalmischen behandlung
EP3684418C0 (de) Verbindungen zur behandlung von cysteaminempfindlichen erkrankungen
EP3313402C0 (de) Vmat2-inhibitoren zur behandlung von neurologischen krankheiten oder störungen
EP3565558A4 (de) Kombinationstherapie zur behandlung von krebs
EP3678663A4 (de) Kombinationstherapie zur behandlung von krebs
EP3263132C0 (de) Zusammensetzung zur behandlung von il-6-assoziierten erkrankungen
EP3362013C0 (de) Energetische vorrichtung zur behandlung einer augenerkrankung
IL273705B (en) Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
EP3880299C0 (de) Vorrichtung zur onkomagnetischen behandlung
EP3863549C0 (de) Vorrichtung zur dermatologischen behandlung
EP3445368C0 (de) Verbindungen und verfahren zur behandlung von neurologischen und kardiovaskulären erkrankungen
EP3915472C0 (de) Vorrichtung zur behandlung von vaginaler atrophie
EP3566055C0 (de) Scd-hemmer zur behandlung von neurologischen erkrankungen
EP3773629A4 (de) Car-treg-basierte therapien zur behandlung von neurodegenerativen erkrankungen
EP3359521C0 (de) Neuartige verbindungen zur behandlung von mitochondrienerkrankungen
EP3618783C0 (de) Vorrichtungen zur behandlung von augenlidern
EP3720509A4 (de) Globingentherapie zur behandlung von hämoglobinopathien
EP3565546A4 (de) Arzneimitteldosierplan zur behandlung von hirnischämie
EP3565540A4 (de) Verfahren zur behandlung von herz-kreislauf-erkrankungen
EP3496708C0 (de) Metaboliten zur behandlung und prävention von autoimmunerkrankungen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BLIVET, GUILLAUME

Inventor name: MOREAU, GUILLAUME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20201014

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: REGENLIFE

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20241004

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

P01 Opt-out of the competence of the unified patent court (upc) registered

Free format text: CASE NUMBER: APP_4093/2025

Effective date: 20250124

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018080240

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: FRENCH

P04 Withdrawal of opt-out of the competence of the unified patent court (upc) registered

Free format text: CASE NUMBER: APP_18376/2025

Effective date: 20250416

U01 Request for unitary effect filed

Effective date: 20250411

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI

Effective date: 20250422

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 8

Effective date: 20250513

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 3030782

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20250702

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250619

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20250611

Year of fee payment: 8

Ref country code: GB

Payment date: 20250507

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NO

Payment date: 20250513

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250319

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250620

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20250625

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20250507

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250319

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250319

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250319

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250319

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250719